the antidepressant efficacy of moclobemide ( 300-600 mg/d ; n = 164 ) was found to be superior to that of placebo ( n = 162 ) and comparable to that of imipramine ( 100-200 mg/d ; n = 164 ) in a 6-w. , double-blind , multicentre study , in patients suffering from a major depressive episode ( dsm-iii ) .
C0003289
antidepressant
C0020934
imipramine